Petros Pharmaceuticals's total assets for Q3 2023 were $38.91M, an increase of 35.46% from the previous quarter. PTPI total liabilities were $31.86M for the fiscal quarter, a 101.85% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.